METHODS: Patients who underwent THA surgery in 2020 were included in the study. The inclusion criteria were elective THA patients aged ≥45 years, while emergency, revision, and simultaneous bilateral THA surgeries were excluded. The patients were categorized into 4 groups based on the CCS guidelines.
RESULTS: The study included 669 patients who had an average age of 67 years. There were 43 patients (6.4%), who experienced a rise in troponin levels ≥30 ng/L and developed myocardial injury after noncardiac surgery. Among these patients, 8 developed cardiac complications, and one experienced a serious cardiac event that resulted in death. Notably, there was a significant increase in the length of hospital stay for patients who received the postoperative screening protocol.
CONCLUSIONS: The implementation of the CCS guidelines for routine postoperative troponin testing in elective THA surgery did not significantly decrease the rate of cardiac events or mortality.
方法:将2020年接受THA手术的患者纳入研究。纳入标准为年龄≥45岁的选择性THA患者,在紧急情况下,修订版,排除了同时进行的双侧THA手术。根据CCS指南将患者分为四组。
结果:该研究包括669名平均年龄为67岁的患者。有43名患者(6.4%),在非心脏手术(MINS)后,肌钙蛋白水平升高≥30ng/L并发生心肌损伤。在这些患者中,八个发展的心脏并发症,其中一人经历了导致死亡的严重心脏事件。值得注意的是,接受术后筛查方案的患者的住院时间显著延长.
结论:在选择性THA手术中实施常规术后肌钙蛋白检测的CCS指南并未显著降低心脏事件或死亡率。